CLINICAL_TRIALS ClinicalTrials.gov record update

The Effectiveness of High-Dose Synthetic BH4 (Saproterin Dihydrochloride or "Kuvan") in Amish PKU Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02677870
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:41.703663+00:00
Published At: 2022-04-27T00:00:00+00:00
Record Updated At: 2022-04-27
Results Posted At: 2022-04-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Phenylketonuria"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-27"
protocolSection.identificationModule.nctId: "NCT02677870"
protocolSection.identificationModule.officialTitle: "The Effectiveness of High-Dose Synthetic BH4 (Saproterin Dihydrochloride or \"Kuvan\") in Amish PKU Patients"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-04-27"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.